Compare KRYS & EXLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRYS | EXLS |
|---|---|---|
| Founded | 2015 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 6.6B |
| IPO Year | 2017 | 2006 |
| Metric | KRYS | EXLS |
|---|---|---|
| Price | $279.47 | $40.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 4 |
| Target Price | ★ $250.50 | $53.00 |
| AVG Volume (30 Days) | 299.1K | ★ 1.0M |
| Earning Date | 02-18-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 275.72 | 29.94 |
| EPS | ★ 6.66 | 1.48 |
| Revenue | $373,164,000.00 | ★ $2,026,490,000.00 |
| Revenue This Year | $36.14 | $15.32 |
| Revenue Next Year | $42.38 | $11.37 |
| P/E Ratio | $41.84 | ★ $28.83 |
| Revenue Growth | ★ 54.51 | 14.43 |
| 52 Week Low | $122.80 | $37.30 |
| 52 Week High | $295.98 | $52.43 |
| Indicator | KRYS | EXLS |
|---|---|---|
| Relative Strength Index (RSI) | 62.12 | 38.20 |
| Support Level | $275.00 | $41.47 |
| Resistance Level | $294.64 | $43.19 |
| Average True Range (ATR) | 11.68 | 0.87 |
| MACD | -0.51 | -0.17 |
| Stochastic Oscillator | 68.67 | 7.37 |
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
ExlService Holdings Inc. is a business process management company that provides digital operations and analytical services to clients driving enterprise-scale business transformation initiatives that leverage the company's deep expertise in analytics, AI, ML, and cloud. The company offers business process outsourcing and automation services, and data-driven insights to customers across multiple industries. The company operates through four segments based on the products and services offered and markets served: Insurance, Healthcare, Emerging Business, and Analytics . The vast majority of the company's revenue is earned in the United States, and more than half of its revenue comes from Analytics segment.